UFP Technologies (NASDAQ:UFPT) Sets New 52-Week High at $250.69

UFP Technologies, Inc. (NASDAQ:UFPT)’s stock price reached a new 52-week high during trading on Wednesday . The company traded as high as $250.69 and last traded at $250.69, with a volume of 13660 shares traded. The stock had previously closed at $240.62.

Analyst Upgrades and Downgrades

UFPT has been the topic of several research reports. StockNews.com upgraded UFP Technologies from a “sell” rating to a “hold” rating in a research note on Thursday, February 22nd. KeyCorp started coverage on UFP Technologies in a research report on Tuesday, February 6th. They set a “sector weight” rating on the stock. Finally, CJS Securities began coverage on shares of UFP Technologies in a report on Wednesday, March 20th. They issued an “outperform” rating and a $255.00 price objective for the company.

UFP Technologies Trading Up 0.0 %

The firm has a market cap of $1.93 billion, a P/E ratio of 43.11 and a beta of 0.81. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.28 and a current ratio of 2.48. The firm has a fifty day moving average of $196.15 and a 200-day moving average of $174.04.

UFP Technologies (NASDAQ:UFPT) last posted its earnings results on Wednesday, February 21st. The industrial products company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.41. The company had revenue of $101.50 million for the quarter, compared to analysts’ expectations of $94.80 million. UFP Technologies had a return on equity of 25.48% and a net margin of 11.23%. Equities research analysts forecast that UFP Technologies, Inc. will post 6.19 earnings per share for the current year.

Insider Buying and Selling at UFP Technologies

In other news, CEO R Jeffrey Bailly sold 27,090 shares of UFP Technologies stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $209.48, for a total transaction of $5,674,813.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, CEO R Jeffrey Bailly sold 27,090 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $209.48, for a total value of $5,674,813.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Steve Cardin sold 311 shares of UFP Technologies stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $196.50, for a total value of $61,111.50. Following the sale, the vice president now directly owns 5,643 shares in the company, valued at approximately $1,108,849.50. The disclosure for this sale can be found here. Insiders sold 31,125 shares of company stock valued at $6,511,420 in the last ninety days. Company insiders own 7.80% of the company’s stock.

Institutional Trading of UFP Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Federated Hermes Inc. increased its stake in shares of UFP Technologies by 98.6% during the fourth quarter. Federated Hermes Inc. now owns 147 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 73 shares during the period. Principal Securities Inc. acquired a new position in shares of UFP Technologies during the 4th quarter valued at $28,000. Macquarie Group Ltd. bought a new stake in shares of UFP Technologies in the 4th quarter worth $34,000. Ronald Blue Trust Inc. acquired a new stake in shares of UFP Technologies in the third quarter valued at $48,000. Finally, Point72 Asset Management L.P. bought a new position in UFP Technologies during the fourth quarter valued at about $43,000. 87.28% of the stock is currently owned by institutional investors.

About UFP Technologies

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.